                         SEQUENCE LISTING

<110>  Northwestern University
 
<120>  Brush Polymers for Therapeutic Applications

<130>  338465: 118-18 WO

<150>  US 62/885,655
<151>  2019-08-12

<150>  US 63/025,388
<151>  2020-05-15

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  1

Gly Gly Gly Cys Tyr Phe Gln Asn Cys Pro Lys Gly 
1               5                   10          


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  2

Cys Tyr Phe Gln Asn Cys Pro Arg Gly 
1               5                   


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  3

Pro Cys Ala Ile Trp Phe 
1               5       


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  allo-Isoleucine

<400>  4

Gly Val Xaa Ser Gln Ile Arg Pro 
1               5               


<210>  5
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  5

Ser His Cys His Trp Asn Asp Leu Ala Val Ile Pro Ala Gly Val Val 
1               5                   10                  15      


His Asn Trp Asp Phe Glu Pro Arg Lys Val Ser 
            20                  25          


<210>  6
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  6

Gly Arg Gly His Leu Leu Gly Arg Leu Ala Ala Ile Val Gly Lys Gln 
1               5                   10                  15      


Val Leu Leu Gly Arg Lys Val Val Val Val Arg 
            20                  25          


<210>  7
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  7

Ser Lys Pro Ser Phe Gln Glu Phe Val Asp Trp Glu Asn Val Ser Pro 
1               5                   10                  15      


Glu Leu Asn Ser Thr Asp Gln Pro Phe Leu 
            20                  25      


<210>  8
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  8

Arg Glu Gly Val Glu Leu Cys Pro Gly Asn Lys Tyr Glu Met Arg Arg 
1               5                   10                  15      


His Gly Thr Thr His Ser Leu Val Ile His Asp 
            20                  25          


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  9

Val Asp Trp Glu Asn Val Ser Pro Glu Leu Asn Ser Thr Asp Gln 
1               5                   10                  15  


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  10

Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   


<210>  11
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  11

Cys Lys Gly Lys Gly Ala Lys Cys Ser Arg Leu Met Tyr Asp Cys Cys 
1               5                   10                  15      


Thr Gly Ser Cys Arg Ser Gly Lys Cys 
            20                  25  


<210>  12
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  12

Ala Asp Asn Lys Cys Asn Ser Leu Arg Arg Glu Ile Ala Cys Gly Gln 
1               5                   10                  15      


Cys Arg Asp Lys Val Lys Thr Asp Gly Tyr Phe Tyr Glu Cys Cys Thr 
            20                  25                  30          


Ser Asp Ser Thr Phe Lys Lys Cys Gln Asp Leu Leu His 
        35                  40                  45  


<210>  13
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  13

Glu Glu Ser Met Leu Leu Ser Cys Pro Asp Leu Ser Cys Pro Thr Gly 
1               5                   10                  15      


Tyr Thr Cys Asp Val Leu Thr Lys Lys Cys Lys Arg Leu Ser Asp Glu 
            20                  25                  30          


Leu Trp Asp His 
        35      


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  14

Gly Cys Cys Ser Asp Pro Arg Cys Arg Tyr Arg Cys Arg 
1               5                   10              


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  15

Pro Val Asn Phe Lys Phe Leu Ser His 
1               5                   


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  misc_feature
<222>  (6)..(7)
<223>  Hydroxyproline

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  3,4-dihydroxyphenylalanine (DOPA)

<400>  16

Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa Lys 
1               5                   10  


<210>  17
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  17

Leu Ala Gly Gly Trp Gly Glu Arg Asp Gly Ser 
1               5                   10      


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  18

Pro Ser Ala Ile Trp Phe 
1               5       


<210>  19
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  19

Gly Pro Leu Gly Leu Ala Gly Gly Trp Gly Glu Arg Asp Gly Ser 
1               5                   10                  15  


<210>  20
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  20

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


